Stock Information
Vanda Pharmaceuticals Inc (VNDA)
Ticker Symbol: VNDA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $413.68 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -3.7362
Revenue (TTM): $3.66 M
Dividend Yield: N/A%
ROE: -49.24%
Latest News
-
Curious about the stocks that are showing activity after the closing bell on Friday?
Fri, May 1, 2026 9:00 PM
-
Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS™ (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years
Fri, May 1, 2026 4:37 PM
-
Vanda Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026
Wed, Apr 29, 2026 4:31 PM
-
Reported Earlier, Vanda Pharmaceuticals Announces NEJM Evidence Publication Of Imsidolimab Phase III Data Ahead Of FDA Action Date December 12, 2026
Wed, Apr 29, 2026 2:55 AM
-
Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence
Tue, Apr 28, 2026 7:14 PM
Key Financials
Financial data not available
